[{"Assets_0_FY_USD":48806000000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":3.53,"EarningsPerShareBasic_4_FY_USD":6.15,"EarningsPerShareDiluted_4_FY_USD":6.12,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":7260700000.0,"NetIncomeLoss_4_FY_USD":5581700000.0,"Revenues_4_FY_USD":28318400000.0,"StockholdersEquity_0_FY_USD":8979200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":911681000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":906963000.0,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20220223"}]